Study links warfarin use to lower cancer risk | Best-ranked cardiac hospitals emphasize care continuum | Study compares effect of lifestyle changes, medications on diabetes risk
November 8, 2017
ASNC SmartBrief
News for nuclear cardiology and cardiovascular imaging professionals
Top Stories
Study links warfarin use to lower cancer risk
A Norwegian study in JAMA Internal Medicine found patients who used warfarin for atrial fibrillation or atrial flutter had a 16% lower risk of all cancers, compared with those who did not use the drug. The findings, based on data for over 1.25 million individuals ages 50 and older, also showed a strong association between warfarin use and a lower risk for lung, prostate, colon and breast cancers.
MedPage Today (free registration) (11/6),  Medical News Today (11/6) 
LinkedIn Twitter Facebook Google+ Email
Best-ranked cardiac hospitals emphasize care continuum
Hospitals that get top rankings for cardiac care in the US are focused on ways to address the patient care continuum, providing support and services beyond discharge to help reduce readmissions. St. Luke's Boise Medical Center has a 12-week cardiac rehabilitation program that includes a multidisciplinary team that provides education, help with personal issues, and exercise and nutrition courses.
Modern Healthcare (tiered subscription model) (11/4) 
LinkedIn Twitter Facebook Google+ Email
Medical Focus
Study compares effect of lifestyle changes, medications on diabetes risk
Researchers conducted a meta-analysis of 43 randomized clinical trials including 49,029 participants and found that lifestyle modification studies showed a 39% reduction in the relative risk of diabetes, compared with a 36% reduction in studies of medications and a risk difference of 4.0 cases per 100 person-years in studies involving both lifestyle modification and medications. The findings in JAMA Internal Medicine revealed that diabetes risk was reduced by 28% in lifestyle modification studies at the end of follow-up, while risk reduction was not sustained in studies of medications after therapy was discontinued by patients.
Healio (free registration) (11/6) 
LinkedIn Twitter Facebook Google+ Email
Diabetes patients on insulin may benefit from bariatric surgery, study finds
A study presented at Obesity Week 2017 showed that 51% of insulin-treated type 2 diabetes patients met the primary A1C outcome of less than 7% without insulin use one to two years after undergoing Roux-en-Y gastric bypass or sleeve gastrectomy, while 44% met the primary outcome five years or more after the procedure. Researchers used a cohort of 252 patients and found that bariatric surgery also led to diabetes remission, weight loss, reductions in LDL cholesterol, diastolic blood pressure, systolic blood pressure and triglycerides, and increase in HDL cholesterol.
Medscape (free registration) (11/6) 
LinkedIn Twitter Facebook Google+ Email
Regulatory & Policy
Clinicians hone detective skills as value-based care takes hold
Clinicians hone detective skills as value-based care takes hold
(Spencer Platt/Getty Images)
Physicians and other health care providers are expanding the medical paradigm and considering factors such as employment and housing as changes in reimbursement structures shift the focus to population health. Health care providers increasingly work together and with community organizations, but the shift to a full population health-centric model will be gradual and is complicated by political uncertainty, says Trissa Torres of the Institute for Healthcare Improvement.
U.S. News & World Report (11/1) 
LinkedIn Twitter Facebook Google+ Email
Record number of people signed up early for ACA plans, sources say
Affordable Care Act plan sign-ups in the first few days of open enrollment this year reportedly exceeded last year's exchange activity, despite fears that outreach and advertising cuts would suppress enrollment. A source close to the process said over 200,000 shoppers selected plans on the first day of enrollment, up from about 100,000 last year, while the number of people who visited that day increased to more than 1 million this year from about 750,000 last year.
The Hill (11/6) 
LinkedIn Twitter Facebook Google+ Email
ASNC2017 Meeting On Demand now available
The ASNC2017 Scientific Session On Demand includes over 52 hours of sessions and presentations from the 22nd Annual Scientific Session of the American Society of Nuclear Cardiology. Highlights include current best practices, new ideas and emerging technology, radiation safety and appropriate use criteria in the nuclear cardiology clinical practice. NEW this year -- video recordings of 10 select sessions.
LinkedIn Twitter Facebook Google+ Email
Time to play "What Is This Image?" Deadline is Nov. 20!
Test your skills against other colleagues and submit your interpretation of our featured nuclear cardiology image. Win an ASNC Gift Pack and, possibly, FREE registration to ASNC's Annual Meeting in 2018. Deadline is Nov. 20.
LinkedIn Twitter Facebook Google+ Email
Learn more about ASNC:
ASNC Home | Join ASNC | Online Education
Live Meetings | Journal of Nuclear Cardiology
We are all failures -- at least all the best of us.
J.M. Barrie,
LinkedIn Twitter Facebook Google+ Email
Sign Up
SmartBrief offers 200+ newsletters
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Editor  -  Tara Rosenzweig
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information